Overview

Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the possible efficacy of low dose, orally administered interferon alpha in subjects with Idiopathic Pulmonary Fibrosis (IPF).
Phase:
Phase 2
Details
Lead Sponsor:
Texas Tech University Health Sciences Center
Collaborator:
Amarillo Biosciences, Inc.
Treatments:
Interferon-alpha
Interferons